Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome
Clinical trial NCT00666224 · COMPLETED
Trial details
- NCT number
- NCT00666224
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2007-10-01
- Enrollment
- 481
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.